NCT03959280

Brief Summary

This study evaluates the addition of a comprehensive lifestyle program including dietary management and exercise to continuous positive airway pressure (CPAP) therapy in overweighted adults with obstructive sleep apnea. Half of the participants will receive CPAP therapy while the other half will have diet consultations, nordic walking sessions and CPAP.

Trial Health

47
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
120

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Aug 2019

Longer than P75 for not_applicable

Geographic Reach
2 countries

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2019

Completed
8 days until next milestone

First Posted

Study publicly available on registry

May 22, 2019

Completed
3 months until next milestone

Study Start

First participant enrolled

August 21, 2019

Completed
3.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

August 9, 2021

Status Verified

August 1, 2021

Enrollment Period

3.3 years

First QC Date

May 14, 2019

Last Update Submit

August 5, 2021

Conditions

Keywords

obstructive sleep apneaCPAP therapyexercisedietquality of life

Outcome Measures

Primary Outcomes (1)

  • Health-related quality of life: SF-36

    Mean difference in the general health perception (GH) domain on the Medical Outcome Study Short Form (SF-36) between groups

    12 weeks

Secondary Outcomes (41)

  • General quality of life: SF-36

    12 and 24 weeks

  • Specific quality of life: Calgary Sleep Apnea Quality of Life Index (SAQLI)

    12 and 24 weeks

  • Daytime excessive sleepiness

    12 and 24 weeks

  • Subjective sleep quality

    12 and 24 weeks

  • Mood

    12 and 24 weeks

  • +36 more secondary outcomes

Study Arms (2)

Tailored intervention

EXPERIMENTAL

In this group, participants will receive a comprehensive lifestyle program in addition to CPAP therapy which will include a supervised exercise program, diet interventions and behavioural counselling during 12 weeks. Then, participants will follow a real-world maintenance program from weeks 12 to 24. It will include one telephone-based contact per month with the study coordinator. Participants will be encouraged to maintain their lifestyle modification during this phase.

Other: Tailored intervention

Control

ACTIVE COMPARATOR

Participant in this group will benefit from routine CPAP therapy management from week 0 to 24.

Other: Control

Interventions

* The exercise program consists of 2 x 1.5-hour supervised nordic walking sessions weekly during 12 weeks and 1-hour unsupervised moderate physical activity per week from week 4. * The diet intervention includes one face-to-face consultation with a dietician and one telephone-based contact monthly, i.e. 6 diet interventions for 12 weeks. * Behavioural changes techniques will be included in diet and exercise interventions.

Also known as: TINE
Tailored intervention
ControlOTHER

This intervention will include tailored instruction on CPAP use and standard advices on physical activity and nutrition at CPAP initiation.

Also known as: CPAP
Control

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients newly diagnosed for obstructive sleep apnea and requiring CPAP therapy
  • BMI\>25and≤40kg/m2
  • Low physical activity (\< 150 min of MVPA per week)
  • IAH≥15
  • Able to give informed consent as documented by signature

You may not qualify if:

  • Patients already treated for OSA or another sleep disorder
  • Required use of supplemental oxygen
  • Active infection, malignancy or chronic inflammatory disorders
  • More than moderate alcohol use of \> 14 drinks per week
  • Severe depression defined by a BDI \> 30
  • Surgery within the previous 3 months
  • Known cardiac or pulmonary disease contraindicating exercise training
  • Patient with a bariatric surgery project or already operated
  • Pregnant or lactating women
  • Onset of a severe cardiac disease contraindicating exercise training
  • Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, peripheral functional limitation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Centre Hospitalier Universitaire Saint-Etienne

Saint-Etienne, 42055, France

RECRUITING

Centre Hospitalier Universitaire Vaudois

Lausanne, 1011, Switzerland

RECRUITING

Related Links

MeSH Terms

Conditions

Sleep Apnea SyndromesOverweightObesitySleep Apnea, ObstructiveMotor Activity

Condition Hierarchy (Ancestors)

ApneaRespiration DisordersRespiratory Tract DiseasesSleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Raphael Heinzer, MD, PhD

    University Hospital of Lausanne, Switzerland

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Mathieu Berger, PhD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Prospective, multicentric, randomized controlled trial
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Prof.

Study Record Dates

First Submitted

May 14, 2019

First Posted

May 22, 2019

Study Start

August 21, 2019

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

August 9, 2021

Record last verified: 2021-08

Data Sharing

IPD Sharing
Will not share

Locations